Erica Reed, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 6201 Greenbelt Rd, Suite U-4, Berwyn Heights, MD 20740 Phone: 240-601-7307 Fax: 301-808-3893 |
Mrs. Kristina Gilbertson, LCSW-C Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 6201 Greenbelt Rd, Suite U-18, Berwyn Heights, MD 20740 Phone: 301-345-1919 Fax: 301-345-5779 |
Mrs. Gillian Andrea Blackman-diarra, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 6201 Greenbelt Rd Ste U4, Berwyn Heights, MD 20740 Phone: 240-354-8552 Fax: 301-735-5294 |
News Archive
Research suggests that fetal exposure to mycophenolic acid products (MPA)—which are drugs taken by transplant recipients to prevent rejection—may increase the risk of birth defects and spontaneous abortions. Results of this study will be presented at ASN Kidney Week 2013 November 5-10 at the Georgia World Congress Center in Atlanta, GA.
In a statement released on Monday, WHO Director-General Margaret Chan said "[s]everal recent media articles are creating misinformation and confusion in the public health arena" by "erroneously suggesting that, in working to reduce non-communicable diseases (NCDs) such as cardiovascular diseases, cancers, chronic respiratory diseases and diabetes, WHO receives funding from the food and beverage industry," the U.N. News Centre reports.
The Republican presidential nominee doesn't offer details on his plans for Medicare or the health care law. Nonetheless, several outlets look at what's ahead on that topic from the GOP ticket.
Silence Therapeutics plc announces the issuance of United States patent 7,772,203, titled "Methods and Compositions for Controlling Efficacy of RNA Silencing," by the United States Patent and Trademark Office (USPTO). The issued patent generally claims methods of enhancing RNA silencing with a double stranded RNA interference (RNAi) agent. The patent's RNA silencing method claims include coverage for the administering of a pharmaceutical composition containing short interfering RNA (siRNA), micro RNA (miRNA), pre-miRNA or short hairpin (shRNA) molecules. Silence believes the proprietary structural modification techniques covered in this patent will play a key role in increasing the potential therapeutic efficacy of RNAi therapeutics.
Gastric varices (GV) are an important complication of portal hypertension. As an almost atraumatic method, computed tomography (CT) angiography has been used widely to show the portal vein system. However, the collateral circulation of GV in different locations has been reported only rarely.
› Verified 9 days ago